{"id":"NCT01964560","sponsor":"UCB BIOSCIENCES, Inc.","briefTitle":"A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures","officialTitle":"A Multicenter, Open-label, Long-term Extension Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Pediatric Subjects With Epilepsy With Partial-Onset Seizures","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-08-13","primaryCompletion":"2022-04-13","completion":"2022-04-13","firstPosted":"2013-10-17","resultsPosted":"2022-10-25","lastUpdate":"2022-10-25"},"enrollment":540,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Epilepsy"],"interventions":[{"type":"DRUG","name":"Lacosamide","otherNames":["VIMPAT"]},{"type":"DRUG","name":"Lacosamide","otherNames":["VIMPAT"]}],"arms":[{"label":"Lacosamide","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the long-term safety, tolerability and efficacy of lacosamide (LCM) in pediatric subjects.","primaryOutcome":{"measure":"Percentage of Participants With Treatment-emergent Adverse Events (TEAEs)","timeFrame":"From Week 0 to the End of Safety Follow-Up (up to Week 104)","effectByArm":[{"arm":"Lacosamide (All Subjects)","deltaMin":77.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Month","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":4},"locations":{"siteCount":141,"countries":["United States","Argentina","Australia","Belgium","Brazil","Bulgaria","China","Colombia","Croatia","Czechia","Estonia","France","Georgia","Greece","Hungary","Israel","Italy","Latvia","Lithuania","Mexico","Moldova","Montenegro","Philippines","Poland","Portugal","Romania","Russia","Serbia","Slovakia","Slovenia","South Korea","Taiwan","Thailand","Ukraine","United Kingdom"]},"refs":{"pmids":[],"seeAlso":["https://www.ucb.com/_up/ucb_com_products/documents/Vimpat_Labeling_Oct_2021.pdf","http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":111,"n":540},"commonTop":["Pyrexia","Upper respiratory tract infection","Nasopharyngitis","Vomiting","Diarrhoea"]}}